TR201911076T4 - Klorür içeriği azaltılmış fosfolipit içeren veya içermeyen hipotonik sulu bileşim. - Google Patents
Klorür içeriği azaltılmış fosfolipit içeren veya içermeyen hipotonik sulu bileşim. Download PDFInfo
- Publication number
- TR201911076T4 TR201911076T4 TR2019/11076T TR201911076T TR201911076T4 TR 201911076 T4 TR201911076 T4 TR 201911076T4 TR 2019/11076 T TR2019/11076 T TR 2019/11076T TR 201911076 T TR201911076 T TR 201911076T TR 201911076 T4 TR201911076 T4 TR 201911076T4
- Authority
- TR
- Turkey
- Prior art keywords
- composition
- aqueous composition
- phospholipids
- chloride content
- reduced chloride
- Prior art date
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 title abstract 2
- 150000003904 phospholipids Chemical class 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 2
- 210000001691 amnion Anatomy 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Mevcut buluş insan veya hayvan vücudunda bir cerrahi veya terapötik tedavi yönteminde veya insan veya hayvan vücudunda gerçekleştirilen tanı amaçlı bir yöntemde kullanım için bir sulu bileşim ile ilgilidir, burada bileşim ozmotik açıdan aktif parçacıklar içerir ve 70 µl-1'den az sayıda amniyon hücresi içerir, burada bileşimin ozmolaritesi 240,0 mosm/l ile 308,0 mosm/l arasındadır ve bileşimdeki klorür iyonu konsantrasyonu en fazla 130,0 mmol/l'dir. Mevcut buluş ayrıca, amniyoinfüzyonda kullanıma yönelik bir sulu bileşim ile ilgilidir, burada bileşimdeki amniyon hücresi sayısı 70 µl-1'den düşüktür ve en az bir sürfaktan içermektedir.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11000044 | 2011-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201911076T4 true TR201911076T4 (tr) | 2019-08-21 |
Family
ID=43982252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/11076T TR201911076T4 (tr) | 2011-01-05 | 2012-01-04 | Klorür içeriği azaltılmış fosfolipit içeren veya içermeyen hipotonik sulu bileşim. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9072755B2 (tr) |
| EP (1) | EP2661308B1 (tr) |
| CN (1) | CN103347566A (tr) |
| DK (1) | DK2661308T3 (tr) |
| EA (1) | EA027317B1 (tr) |
| ES (1) | ES2738914T3 (tr) |
| HR (1) | HRP20191387T1 (tr) |
| HU (1) | HUE045638T2 (tr) |
| PL (1) | PL2661308T3 (tr) |
| PT (1) | PT2661308T (tr) |
| RS (1) | RS59060B1 (tr) |
| TR (1) | TR201911076T4 (tr) |
| WO (1) | WO2012093087A1 (tr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2661308B1 (de) * | 2011-01-05 | 2019-05-08 | Prenatal International GmbH | Hypotone wässrige zusammensetzung mit verringertem chloridgehalt mit oder ohne phospholipide |
| AU2016256979B2 (en) | 2015-05-04 | 2021-01-28 | Versantis AG | Method for preparing transmembrane pH-gradient vesicles |
| HK1256700A1 (zh) | 2015-11-06 | 2019-10-04 | 羊膜生命公司 | 早产儿羊水浴温育器 |
| DE112017007295A5 (de) * | 2017-03-21 | 2020-01-02 | Universitätsklinikum Halle (Saale) | Künstliches Gebärmuttersystem und Plazenta |
| WO2019073435A1 (en) * | 2017-10-12 | 2019-04-18 | Novartis Ag | COMBINATIONS OF MDM2 INHIBITORS WITH ERK INHIBITORS TO TREAT CANCERS |
| WO2019139914A1 (en) | 2018-01-09 | 2019-07-18 | Amnion Life, LLC | Systems, methods, and devices for artificial placentas and amniotic bed incubators |
| IL277468B2 (en) * | 2018-03-29 | 2024-09-01 | Airway Therapeutics Inc | Methods and compositions comprising surfactant protein d (sp-d) |
| CA3094966A1 (en) | 2018-03-29 | 2019-10-03 | Airway Therapeutics, Inc. | Systems and methods for characterizing surfactant protein d (sp-d) oligomers |
| DE102018126634A1 (de) | 2018-10-25 | 2020-04-30 | Prenatal International GmbH Halle | Vorrichtung mit künstlichem Kiemensystem und Verfahren für die Lebenserhaltung eines Neugeborenen |
| EP4062919A1 (de) | 2021-03-24 | 2022-09-28 | Prenatal International GmbH | Eine oder mehrere zusammensetzungen auf basis des menschlichen fruchtwassers zur anwendung in einem verfahren zur enteralen ernährung, zur enteralen ernährungsergänzung und/oder zur behandlung und/oder versorgung von kapillararmen schichten |
| US12419763B2 (en) | 2023-06-07 | 2025-09-23 | Muhammad TAQI | Osmolar devices and methods for preventing tissue swelling |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI243687B (en) | 1998-04-21 | 2005-11-21 | Teijin Ltd | Pharmaceutical composition for application to mucosa |
| DE10359867A1 (de) | 2003-12-18 | 2005-07-14 | Endress + Hauser Gmbh + Co. Kg | Einkopplung |
| CN1921870A (zh) * | 2004-02-27 | 2007-02-28 | 日本多宁股份有限公司 | 人工生理盐溶液及其制备方法 |
| DE102010023438A1 (de) | 2010-06-11 | 2011-12-15 | Universitätsmedizin Der Johannes Gutenberg-Universität Mainz | Ballonkathetersystem zur Ableitung von Flüssigkeiten aus Hohlorganen, Körperhöhlen oder Zysten und/oder zur Zuleitung von Medikamenten |
| EP2661308B1 (de) * | 2011-01-05 | 2019-05-08 | Prenatal International GmbH | Hypotone wässrige zusammensetzung mit verringertem chloridgehalt mit oder ohne phospholipide |
-
2012
- 2012-01-04 EP EP12701434.8A patent/EP2661308B1/de active Active
- 2012-01-04 WO PCT/EP2012/000029 patent/WO2012093087A1/de not_active Ceased
- 2012-01-04 CN CN2012800047929A patent/CN103347566A/zh active Pending
- 2012-01-04 PT PT12701434T patent/PT2661308T/pt unknown
- 2012-01-04 US US13/978,052 patent/US9072755B2/en active Active
- 2012-01-04 ES ES12701434T patent/ES2738914T3/es active Active
- 2012-01-04 HU HUE12701434A patent/HUE045638T2/hu unknown
- 2012-01-04 DK DK12701434.8T patent/DK2661308T3/da active
- 2012-01-04 TR TR2019/11076T patent/TR201911076T4/tr unknown
- 2012-01-04 HR HRP20191387 patent/HRP20191387T1/hr unknown
- 2012-01-04 RS RS20190950A patent/RS59060B1/sr unknown
- 2012-01-04 EA EA201391006A patent/EA027317B1/ru not_active IP Right Cessation
- 2012-01-04 PL PL12701434T patent/PL2661308T3/pl unknown
-
2015
- 2015-06-17 US US14/741,883 patent/US9682128B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9072755B2 (en) | 2015-07-07 |
| EP2661308A1 (de) | 2013-11-13 |
| PT2661308T (pt) | 2019-07-31 |
| US20130316980A1 (en) | 2013-11-28 |
| HRP20191387T1 (hr) | 2019-11-01 |
| RS59060B1 (sr) | 2019-08-30 |
| EA201391006A1 (ru) | 2013-11-29 |
| WO2012093087A1 (de) | 2012-07-12 |
| CN103347566A (zh) | 2013-10-09 |
| EP2661308B1 (de) | 2019-05-08 |
| HUE045638T2 (hu) | 2020-01-28 |
| US9682128B2 (en) | 2017-06-20 |
| PL2661308T3 (pl) | 2019-10-31 |
| EA027317B1 (ru) | 2017-07-31 |
| DK2661308T3 (da) | 2019-08-12 |
| ES2738914T3 (es) | 2020-01-27 |
| US20150343027A1 (en) | 2015-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201911076T4 (tr) | Klorür içeriği azaltılmış fosfolipit içeren veya içermeyen hipotonik sulu bileşim. | |
| MX394291B (es) | Composiciones de ribosido de nicotinamida para uso topico en el tratamiento de afecciones de la piel. | |
| BR112014015482A2 (pt) | compostos carbamato de fenila para uso no alívio ou tratamento de dor e dor neuropática | |
| BR112014014783A2 (pt) | moléculas de inibidor de jnk para tratamento de várias doenças | |
| ATE526060T1 (de) | Teilchenförmiges antiperspirans-salz mit verbesserter wirksamkeit und erhöhtem ph | |
| RU2013155618A (ru) | Индукция иммунологической толерантности, используя метотрексат | |
| TR201903587T4 (tr) | Telomeraz aktivitesinin artırılması için bileşimler. | |
| BR112018072714A2 (pt) | composições de ligação a hcl para e método de tratamento de distúrbios de ácido-base | |
| JP2014513722A5 (tr) | ||
| MX365007B (es) | Uso de acido lipasa lisosomal para tratar la dificiencia de acido lipasa lisosomal en pacientes. | |
| WO2013126590A8 (en) | Pharmaceutical composition comprising cd34+ cells | |
| BR112015019197A2 (pt) | tratamento de doença de enxerto versus hospedeiro em pacientes transplantados | |
| NZ754328A (en) | Marker for acid sphingomyelinase disorders and uses thereof | |
| EA200600468A1 (ru) | Биполярные транс-каротиноидные соли и их применение | |
| BR112014000721A2 (pt) | método de uso de proteínas funcionais ativadas para aprimorar a saúde animal | |
| Zaitz et al. | Cutaneous protothecosis: report of a third Brazilian case | |
| MX341622B (es) | Una composicion acuosa que comprende un antigeno biologico y un polimero de acido acrilico. | |
| WO2014100746A3 (en) | Tspan 33 is a candidate for antibody targeted therapy for the treatment of b cell hodgkin lymphomas | |
| MX2016004209A (es) | Terapia con celulas de placenta humana y celulas hematopoyeticas. | |
| RU2011134925A (ru) | Способ повышения радиосенсибилизации тканей животных | |
| RU2012130748A (ru) | Способ повышения адаптивного статуса пчелиной семьи | |
| CL2013000771A1 (es) | Formulacion acuosa estable que comprende polipeptido del factor estimulante de colonias de granulocitos bovino (bg-csf); liofilizado de la preparacion; proceso para preparar la formulación; uso para tratar infección en un animal. | |
| RU2012112098A (ru) | Способ увеличения выживаемости кожного лоскута в условиях редуцированного кровообращения миноксидилом | |
| Helaly | The effect of zinc supplementation on the white blood cell and platelet count levels during virus C Hepatitis therapy | |
| Huber et al. | Combudoron® for treating burns—Experimental case studies in humans |